Inventor · disambiguated record
Yongzhang Luo
Also filed as: LUO YONGZHANG
11 granted patents·18 pending applications·27 citations·filing 2002–2023
84Inventor score
Top patents by PatentIndex Score
29 records- 0185US7470667B2Methods of treating cancer using a modified endostatin proteinMEDGENN HONG KONG LTD·Filed 2005·Granted Dec 30, 2008·18 cites·7 claims
- 0275US7078485B2N-terminal modified recombinant human endostatin and its productionYANTAI MEDGENN LTD·Filed 2002·Granted Jul 18, 2006·8 cites·12 claims
- 0372US2024165140A1Medication for inhibiting dna-pkcsUNIV TSINGHUA·Filed 2023·Application pending·0 cites
- 0468US2023174644A1Nucleolin-mediated cancer diagnostics and therapyUNIV TSINGHUA·Filed 2022·Application pending·0 cites
- 0565US10647968B2Endostatin mutants with mutations at ATP binding sitesLUO YONGZHANG·Filed 2012·Granted May 12, 2020·1 cites·6 claims
- 0664US2022409703A1Drug for inhibiting adipose cell differentiation and insulin resistanceUNIV TSINGHUA·Filed 2022·Application pending·0 cites
- 0760US8975030B2Method for cancer detectionUNIV TSINGHUA·Filed 2013·Granted Mar 10, 2015·0 cites·12 claims
- 0858US10054590B2Use of nucleolin as a biomarker for lymphangiogenesis in a cancer prognosis and therapyUNIV TSINGHUA·Filed 2013·Granted Aug 21, 2018·0 cites·18 claims
- 0958US9815906B2Method of inhibiting or treating cancer metastasisUNIV TSINGHUA·Filed 2015·Granted Nov 14, 2017·0 cites·5 claims
- 1057US2020237796A1Medication for inhibiting dna-pkcsUNIV TSINGHUA·Filed 2018·Application pending·0 cites
- 1156US10869910B2Molecular design of recombinant protein drugUNIV TSINGHUA·Filed 2016·Granted Dec 22, 2020·0 cites·7 claims
- 1256US2010184661A1Conjugate comprising angiostation or its fragment, the method for producing the conjugate and use thereofPROTGEN LTD·Filed 2008·Application pending·0 cites
- 1356US2021085754A1Molecular design of recombinant protein drugUNIV TSINGHUA·Filed 2020·Application pending·0 cites
- 1455US9145452B2Application of fibrinogen-420 and its active domainUNIV TSINGHUA·Filed 2013·Granted Sep 29, 2015·0 cites·9 claims
- 1553US8389684B2Tumor biomarkerLUO YONGZHANG·Filed 2010·Granted Mar 5, 2013·0 cites·3 claims
- 1651US11434288B2Nucleolin-mediated cancer diagnostics and therapyLUO YONGZHANG·Filed 2009·Granted Sep 6, 2022·0 cites·15 claims
- 1750US2010285103A1Medicament for treatment of tumors and the use thereofLUO YONGZHANG·Filed 2007·Application pending·0 cites
- 1849US2014056966A1Conjugate angiostation or its fragment, the method of producing the conjugate and use thereofLUO YONGZHANG·Filed 2012·Application pending·0 cites
- 1948US2023265166A1Young and undamaged human serum albumin improves longevity of humanSHENZHEN PROTGEN LTD·Filed 2021·Application pending·0 cites
- 2048US2013023479A1Use of nucleolin as a biomarker for lymphangiogenesis in cancer prognosis and therapyPROTGEN LTD·Filed 2012·Application pending·0 cites
- 2147US2018360922A1Medicament for treatment of tumors and the use thereofUNIV TSINGHUA·Filed 2018·Application pending·0 cites
- 2246US9364493B2Methods and compositions for enhancing the uptake of therapeutic agents by target cellsLUO YONGZHANG·Filed 2012·Granted Jun 14, 2016·0 cites·14 claims
- 2346US2016178633A1Tumor biomarkerUNIV TSINGHUA·Filed 2014·Application pending·0 cites
- 2445US2018094051A1Method for inhibiting lymphangiogenesis by administration of an inhibitor of the cxcl12 pathwayUNIV TSINGHUA·Filed 2017·Application pending·0 cites
- 2545US2006258605A1Nucleolin-mediated cancer diagnostics and therapyLUO YONGZHANG·Filed 2005·Application pending·0 cites
- 2644US2023390364A1Use of human serum albumin in treatment of diseasesSHENZHEN PROTGEN LTD·Filed 2021·Application pending·0 cites
- 2743US2010303893A1Novel compound for treatment of tumorLUO YONGZHANG·Filed 2007·Application pending·0 cites
- 2838US2018015148A1Drug for inhibiting adipose cell differentiation and insulin resistanceUNIV TSINGHUA·Filed 2015·Application pending·0 cites
- 2934US2014193424A1Method and medicament for inhibiting lymphangiogenesisBEIJING PROTGEN LTD·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yongzhang Luo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →